ExodusPoint Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.44M | Sell |
52,227
-290,917
| -85% | -$18.5M | 0.03% | 565 |
|
|
2025
Q4 | $21.8M | Buy |
+343,144
| New | +$21.3M | 0.24% | 95 |
|
|
2025
Q2 | – | Sell |
-85,863
| Closed | -$3.45M | – | 1562 |
|
|
2025
Q1 | $3.45M | Buy |
85,863
+76,539
| +821% | +$3.52M | 0.05% | 527 |
|
|
2024
Q4 | $439K | Sell |
9,324
-108,660
| -92% | -$5.64M | ﹤0.01% | 1182 |
|
|
2024
Q3 | $6.23M | Buy |
117,984
+25,051
| +27% | +$1.4M | 0.06% | 345 |
|
|
2024
Q2 | $5.04M | Buy |
92,933
+47,669
| +105% | +$2.88M | 0.06% | 400 |
|
|
2024
Q1 | $3.17M | Buy |
45,264
+42,130
| +1,344% | +$3.26M | 0.04% | 541 |
|
|
2023
Q4 | $262K | Sell |
3,134
-201,599
| -98% | -$7.3M | ﹤0.01% | 1216 |
|
|
2023
Q3 | $6.03M | Sell |
204,733
-8,159
| -4% | -$272K | 0.08% | 330 |
|
|
2023
Q2 | $6.95M | Sell |
212,892
-57,557
| -21% | -$2.13M | 0.08% | 343 |
|
|
2023
Q1 | $9.52M | Buy |
270,449
+109,116
| +68% | +$4.45M | 0.11% | 291 |
|
|
2022
Q4 | $7.39M | Buy |
+161,333
| New | +$6.94M | 0.11% | 247 |
|
|
2022
Q3 | – | Sell |
-98,740
| Closed | -$3.88M | – | 1951 |
|
|
2022
Q2 | $3.88M | Buy |
+98,740
| New | +$3.98M | 0.05% | 493 |
|
|
2022
Q1 | – | Sell |
-26,013
| Closed | -$1.19M | – | 2285 |
|
|
2021
Q4 | $1.19M | Sell |
26,013
-50,572
| -66% | -$1.95M | 0.01% | 982 |
|
|
2021
Q3 | $2.74M | Buy |
76,585
+45,070
| +143% | +$1.33M | 0.04% | 602 |
|
|
2021
Q2 | $624K | Sell |
31,515
-21,971
| -41% | -$516K | 0.01% | 1244 |
|
|
2021
Q1 | $1.24M | Buy |
+53,486
| New | +$1.14M | 0.03% | 797 |
|
|
2020
Q1 | – | Sell |
-19,384
| Closed | -$206K | – | 1180 |
|
|
2019
Q4 | $206K | Buy |
+19,384
| New | +$199K | 0.01% | 1331 |
|
Other funds holding CYTK
VPM
VCM
ACA
